BIIB112 clinical trials

Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa

This study looks at the long-term safety and effectiveness of treatments (BIIB111 and BIIB112) for two rare eye conditions, Choroideremia (CHM) and X-Linked Retinitis Pigmentosa (XLRP). It's for men who have already received one of these treatments in a previous study.